Controlled Substances - As introduced, requires reports submitted by the medical cannabis commission on or after January 1, 2027, to include an analysis of the effects of Exec. Order No. 14370 and any subsequent federal action on increasing medical marijuana and cannabidiol research. - Amends TCA Title 38; Title 39; Title 40; Title 43; Title 53; Title 67 and Title 68.

SB 1583, a withdrawn bill (withdrawn January 23, 2026), required Tennessee's medical cannabis commission to include in reports submitted on or after January 1, 2027, an analysis of how Executive Order No. 14370 and future federal actions impact medical marijuana and cannabidiol research. The bill amended multiple Tennessee Code sections related to controlled substances to implement this reporting requirement. It directly affected the medical cannabis commission, mandating they assess federal policy impacts on research expansion. The bill did not become law, as it was withdrawn before final passage.